- Home
- BCO vs VKTX Comparison
BCO vs VKTX Comparison
Compare BCO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCO
- VKTX
- Stock Information
- Founded
- BCO 1859
- VKTX 2012
- Country
- BCO United States
- VKTX United States
- Employees
- BCO N/A
- VKTX N/A
- Industry
- BCO Oil Refining/Marketing
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- BCO Consumer Discretionary
- VKTX Health Care
- Exchange
- BCO Nasdaq
- VKTX Nasdaq
- Market Cap
- BCO 4.1B
- VKTX 3.4B
- IPO Year
- BCO N/A
- VKTX 2015
- Fundamental
- Price
- BCO $88.83
- VKTX $23.91
- Analyst Decision
- BCO Strong Buy
- VKTX Strong Buy
- Analyst Count
- BCO 2
- VKTX 11
- Target Price
- BCO $138.00
- VKTX $95.18
- AVG Volume (30 Days)
- BCO 304.8K
- VKTX 3.8M
- Earning Date
- BCO 05-07-2025
- VKTX 04-23-2025
- Dividend Yield
- BCO 1.10%
- VKTX N/A
- EPS Growth
- BCO 94.75
- VKTX N/A
- EPS
- BCO 3.63
- VKTX N/A
- Revenue
- BCO $5,011,900,000.00
- VKTX N/A
- Revenue This Year
- BCO $0.70
- VKTX N/A
- Revenue Next Year
- BCO $4.60
- VKTX N/A
- P/E Ratio
- BCO $23.87
- VKTX N/A
- Revenue Growth
- BCO 2.82
- VKTX N/A
- 52 Week Low
- BCO $82.78
- VKTX $23.27
- 52 Week High
- BCO $115.91
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- BCO 51.92
- VKTX 33.36
- Support Level
- BCO $86.23
- VKTX $23.27
- Resistance Level
- BCO $88.56
- VKTX $29.60
- Average True Range (ATR)
- BCO 2.16
- VKTX 1.52
- MACD
- BCO 0.41
- VKTX -0.38
- Stochastic Oscillator
- BCO 96.65
- VKTX 7.80
About BCO Brinks Company (The)
The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.